
News|Articles|May 8, 2024
Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD
Author(s)Peter J. Weiden, MD, John J. Miller, MD
Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.
Advertisement
CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with his colleague, Peter J. Weiden, MD, of the State University of New York at Stony Brook at the
Dr Weiden is a professor at the State University of New York at Stony Brook.
See more coverage from the 2024 APA Annual Meeting in Psychiatric Times at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FAQ: What Clinicians Need to Know About Postpartum Psychosis
2
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
3
Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report of Rapid Agitation Control and Functional Improvement
4
How Wearable Tech Can Translate Into Practical Precision Medicine in Psychiatry
5










